Journal
JOURNAL OF NATURAL PRODUCTS
Volume 81, Issue 8, Pages 1693-1700Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jnatprod.7b00892
Keywords
-
Funding
- National Research Council Sri Lanka [12-100]
- NIH [R15 CA213185-01A1, R15 GM100440-01]
- NIH Environmental Health Sciences [Z01-ES043010]
- American Heart Association [17AIREA33700076/ZAS/2017]
- College of Pharmacy and Pharmaceutical Sciences, University of Toledo, USA
Ask authors/readers for more resources
A new resveratrol trimer, vateriferol (1), having four cis-oriented methine protons and constituting four contiguous stereocenters, was isolated from the bark extract of Vateria copallifera by bioassay-guided fractionation using a combination of normal, reversed phase, and size exclusion column chromatography. The structure was established based on its spectroscopic data. Vateriferol (1) was evaluated in vitro for its antioxidant capacity, enzyme inhibitory activity, growth inhibitory activity on a number of cancer cell lines, neuroprotective activity, and anti-inflammatory activity. Vateriferol (1) exhibited AChE inhibitory activity (IC50 8.4 +/- 0.2 /mu M), ORAC activity (2079 +/- 0.20 TE/g), and neuroprotective activity at 1.5 mu M using PC12 cells deprived of oxygen and glucose and lowered NO levels in lipopolysaccharide-stimulated SIM-A9 microglial cells at 14.7 and 73.6 mu M. Vateriferol (1) exhibited weak cytotoxic potency (<50% growth inhibition) against the tested cell lines at 147.2 mu M.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available